| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0969005A1 Azabicyclic inhibitors of serotonin reuptake |
| 01/05/2000 | EP0967974A1 Spermicide |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | CN1240450A Thienopyrimidine with phosphodiesterase V inhibiting effect |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/04/2000 | US6011057 Methods for inhibiting uterine fibroid disease |
| 01/04/2000 | US6011051 Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 01/04/2000 | US6011015 Angiotensin II for improving fertilization |
| 01/04/2000 | US6011011 Suspensions of somatotropin and growth hormone releasing factor in low molecular weight polyethylene glycol. |
| 01/04/2000 | US6011005 Administering an effective amount of a fetuin polypeptide. |
| 01/04/2000 | US6011003 Vascular endothelial growth factor (vegf) inhibitors |
| 01/04/2000 | CA2194103C Polypeptides useful as calcium channel blockers |
| 12/30/1999 | DE19828273A1 Transdermal patch useful for controlled release of estradiol and norethisterone acetate |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067276A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds |
| 12/29/1999 | WO1999067275A1 Unsaturated 14,15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds |
| 12/29/1999 | WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067273A1 Meiosis regulating compounds |
| 12/29/1999 | WO1999067271A1 Testosterone derivative |
| 12/29/1999 | WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | WO1999066916A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 12/29/1999 | WO1999066913A2 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein |
| 12/29/1999 | WO1999066909A2 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 12/29/1999 | WO1999066908A1 Matrix-type transdermal patch for steroid hormones |
| 12/29/1999 | WO1999066901A2 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 12/29/1999 | WO1999066870A1 A device and method for the treatment of erectile dysfunction |
| 12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
| 12/29/1999 | WO1999053910A3 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 12/29/1999 | EP0967214A1 Intranasal formulations for treating sexual disorders |
| 12/29/1999 | EP0966470A1 Dioxino derivatives and their use as therapeutic agents |
| 12/29/1999 | EP0966288A1 Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 12/29/1999 | EP0813412B1 Gel for the local hormonotherapy of vaginal dryness |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CN1239944A New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis |
| 12/29/1999 | CN1239893A Hormonal composition consisting of oestrogen compound and progestational compound |
| 12/29/1999 | CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 12/29/1999 | CA2336095A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 12/29/1999 | CA2335736A1 A device and method for the treatment of erectile dysfunction |
| 12/29/1999 | CA2335329A1 Meiosis regulating compounds |
| 12/29/1999 | CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/29/1999 | CA2334550A1 Method and compositions for the treatment or amelioration of female sexual dysfunction |
| 12/29/1999 | CA2333586A1 Matrix-type transdermal patch for steroid hormones |
| 12/29/1999 | CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008199 Continuously infusing an activated protein c for about 24 to 144 hours |
| 12/28/1999 | US6008017 Human cardiac/brain tolloid-like protein |
| 12/28/1999 | US6007824 Orally administering synergistic mixture of l-arginine, ginseng and zizyphi fructus to stimulate release of nitrogen monoxide and cause smooth muscle relaxation in human body |
| 12/23/1999 | WO1999065940A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 12/23/1999 | WO1999065897A1 Inhibitors of glycogen synthase kinase 3 |
| 12/23/1999 | WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 12/23/1999 | WO1999065893A1 Novel benzopyran or thiobenzopyran derivatives |
| 12/23/1999 | WO1999065523A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 12/23/1999 | WO1999065521A1 Methods and materials for the treatment of prostatic carcinoma |
| 12/23/1999 | WO1999065520A1 Egg surface proteins and methods for use for modulating fertility |
| 12/23/1999 | WO1999065497A1 Vaginal active agent delivery procedures and formulations thereof |
| 12/23/1999 | WO1999065492A1 Inhibition of serotonin reuptake |
| 12/23/1999 | WO1999065487A1 Inhibitors of serotonin reuptake |
| 12/23/1999 | WO1999065303A1 Composition and method for treating penile erectile dysfunction |
| 12/23/1999 | DE19827732A1 Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms |
| 12/23/1999 | DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction |
| 12/23/1999 | DE19827523A1 New unsaturated 14,15-cyclopropano-androstanes useful in fertility control and for treating e.g. hypogonadism, endometriosis or mammary carcinoma |
| 12/23/1999 | DE19827522A1 New derivatives of 19-norandrostane useful in fertility control or treatment of e.g. endometriosis, mammary carcinoma or hypogonadism |
| 12/23/1999 | CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 12/23/1999 | CA2335337A1 Methods and materials for the treatment of prostatic carcinoma |
| 12/23/1999 | CA2335336A1 Inhibition of serotonin reuptake |
| 12/23/1999 | CA2335322A1 Inhibitors of serotonin reuptake |
| 12/23/1999 | CA2335255A1 Vaginal active agent delivery procedures and formulations thereof |
| 12/23/1999 | CA2334634A1 Novel benzopyran or thiobenzopyran derivatives |
| 12/23/1999 | CA2331332A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | CA2328504A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 12/22/1999 | EP0965595A1 Protein complex |
| 12/22/1999 | EP0965587A1 Tetrahydropyridinyl- and piperidinyl Inhibitors of serotonin reuptake |
| 12/22/1999 | EP0964852A1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 12/22/1999 | EP0964696A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor |
| 12/22/1999 | CN1239429A Methods for minimizing bone loss |
| 12/22/1999 | CN1238947A Foaming medicine for treating gynopathy and preparing process thereof |
| 12/21/1999 | US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists |
| 12/21/1999 | US6005010 Cardiovascular disorders, antiarrhythmia agents and antiischemic agents |
| 12/21/1999 | US6004991 Compounds for cosmetics with enantiomorphs |
| 12/21/1999 | US6004586 Contacting sperm with purified polypeptide having seqeunce defined in part by truncated portion of prosaposin molecule; contacting sperm with investments of one or more oocytes |
| 12/21/1999 | US6004556 Staphylococcus aureus RSBU-1 |
| 12/21/1999 | CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 12/16/1999 | WO1999064596A2 Proteins regulating gene expression |
| 12/16/1999 | WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 12/16/1999 | WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 12/16/1999 | WO1999064064A1 Acrosomal sperm protein and uses thereof |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | WO1999064041A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | WO1999064038A1 Novel analgesic agents |
| 12/16/1999 | WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS |